The Chinese experience reported 917 children with con- firmed COVID-19
infections, and none of them had the diag- nosis of
IBD. In Korea, from 8,413 children with confirmed COVID-19 diagnosis,
272 (3.2%) had IBD and almost all (99.3%) continued IBD
treatment. Among 4.8% of children that postponed biological infusion, 23%
experienced an IBD flare.